Optimizing cardiovascular risk reduction during antihypertensive therapy.
Weinberger
M H
MH
Hypertension Research Center, Indiana University School of Medicine, Indianapolis 46202-5111.
D000959:Antihypertensive Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000150:complications; D006332:Cardiomegaly / Q000150:complications; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D004232:Diuretics / Q000494:pharmacology; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007333:Insulin Resistance; D009765:Obesity / Q000150:complications; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D000959:Antihypertensive Agents; D004232:Diuretics